Gill; Alan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gill; Alan.The latest application filed is for "anti-cd40l antibodies and methods for treating cd40l-related diseases or disorders".

Company Profile

6.12.13

Gill; Alan - Reading MA
Gill; Alan - Prior Lake MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd40l Antibodies And Methods For Treating Cd40l-related Diseases Or Disorders App 20210269538 - Lincecum; John M. ; et al.	2021-09-02
Anti-CD40L antibodies Grant 11,014,990 - Lincecum , et al. May 25, 2	2021-05-25
Copper Complexes For Treatment Of Neurodegenerative Disorders App 20210038676 - Perrin; Steven ; et al.	2021-02-11
Targeting Of Endoplasmic Reticulum Dysfunction And Protein Folding Stress To Treat Neurological Conditions App 20210009558 - GILL; Alan ; et al.	2021-01-14
Anti-cd40l Antibodies And Methods For Treating Cd40l-related Diseases Or Disorders App 20200277391 - Lincecum; John M. ; et al.	2020-09-03
Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodies Grant 10,683,356 - Lincecum , et al.	2020-06-16
Anti-cd40l Antibodies And Methods For Treating Cd40l-related Diseases Or Disorders App 20190092868 - Lincecum; John M. ; et al.	2019-03-28
Anti-CD40L antibodies Grant 10,106,618 - Lincecum , et al. October 23, 2	2018-10-23
Anti-cd40l Antibodies And Methods For Treating Cd40l-related Diseases Or Disorders App 20170342158 - Lincecum; John M. ; et al.	2017-11-30
Measurement Of ALS Progression Based On Kinetic Data App 20170231558 - Gill; Alan ; et al.	2017-08-17
Systems And Methods For Fuel State Control With Fuel Recirculation And Preheat App 20160186706 - Hawley; Matthew ; et al.	2016-06-30
Method for the treatment of neurodegenerative diseases Grant 9,044,459 - Perrin , et al. June 2, 2	2015-06-02
Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis Grant 8,946,301 - Perrin , et al. February 3, 2	2015-02-03
Method of treating lung fibrosis using ST2 polypeptide Grant 8,865,645 - Amatucci , et al. October 21, 2	2014-10-21
Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases Grant 8,673,308 - Perrin , et al. March 18, 2	2014-03-18
Method for the Treatment of Neurodegenerative Diseases App 20130295092 - Perrin; Steven ; et al.	2013-11-07
Method for the treatment of neurodegenerative diseases Grant 8,435,514 - Perrin , et al. May 7, 2	2013-05-07
Targeting Of Cd8+ T-lymphocytes To Treat Neurodegenerative Diseases App 20120237505 - Perrin; Steven ; et al.	2012-09-20
Method for the Treatment of Neurodegenerative Diseases App 20110293612 - Perrin; Steven ; et al.	2011-12-01
Methods Of Treating Fibrosis App 20090304699 - Amatucci; Aldo ; et al.	2009-12-10
Lymphotoxin beta receptor agents in combination with chemotherapeutic agents App 20060134102 - LePage; Doreen ; et al.	2006-06-22
VLA-4 inhibitor: oMePUPA-V Grant 6,495,525 - Lee , et al. December 17, 2	2002-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.